|
FKBP8 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
Statistics: Unpaired two sample T-test was employed to evaluate levels of significance in expression level between any two sample groups
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.548200E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.458800E-01 |
| Normal-vs-Stage2 |
7.022600E-01 |
| Normal-vs-Stage3 |
1.626820E-01 |
| Normal-vs-Stage4 |
9.552400E-01 |
| Stage1-vs-Stage2 |
8.800400E-01 |
| Stage1-vs-Stage3 |
9.648400E-02 |
| Stage1-vs-Stage4 |
9.021600E-01 |
| Stage2-vs-Stage3 |
1.827020E-01 |
| Stage2-vs-Stage4 |
8.560800E-01 |
| Stage3-vs-Stage4 |
3.989800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.788600E-01 |
| Normal-vs-AfricanAmerican |
7.381200E-01 |
| Normal-vs-Asian |
3.829600E-01 |
| Caucasian-vs-AfricanAmerican |
8.934200E-01 |
| Caucasian-vs-Asian |
3.580200E-01 |
| AfricanAmerican-vs-Asian |
3.511200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.937800E-01 |
| Normal-vs-Female |
3.763800E-01 |
| Male-vs-Female |
1.139780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
6.542800E-01 |
| Normal-vs-Extreme_Weight |
6.074200E-01 |
| Normal-vs-Obese |
8.260400E-01 |
| Normal-vs-Extreme_Obese |
9.439000E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.102800E-01 |
| Normal_Weight-vs-Obese |
7.821600E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.752200E-01 |
| Extreme_Weight-vs-Obese |
4.725800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.312600E-01 |
| Obese-vs-Extreme_Obese |
9.835200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.018230E-01 |
| Normal-vs-Age(41-60Yrs) |
8.339600E-01 |
| Normal-vs-Age(61-80Yrs) |
6.433400E-01 |
| Normal-vs-Age(81-100Yrs) |
1.692820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.065600E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.070100E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.046300E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.851400E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.340000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.824800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
8.739200E-01 |
| Normal-VS-Type2 PRCC |
1.228570E-01 |
| Normal-VS-KIRP CIMP |
1.396750E-03 |
| Normal-VS-Unclassified PRCC |
9.221800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
4.824300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
9.880700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
9.974600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.223400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.122600E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.181900E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.896000E-01 |
| Normal-vs-N1 |
5.420000E-01 |
| Normal-vs-N2 |
5.108200E-01 |
| N0-vs-N1 |
4.851600E-01 |
| N0-vs-N2 |
2.366200E-01 |
| N1-vs-N2 |
4.442600E-01 |
|
|
